Loading

Revolutionizing Drug Development: Harnessing New Approach Methodologies (NAMs) for a Safer Future in Medicine

June 18, 2025
Breakout Session
Translational Research
New Approach Methodologies (NAMs) are at the forefront of transforming how biomedical research translates into real-world treatments, enabling faster and more precise drug development by, in some cases, bypassing traditional animal models. This session will explore the pivotal role NAMs play in advancing translational research, effectively bridging the gap between laboratory discoveries and clinical applications. Participants will gain a comprehensive understanding of how NAMs are reshaping the journey from basic research to regulatory testing, offering a more ethical, efficient, and scientifically robust pathway to safer and more effective therapies.
Moderator
Giulia Del Brenna
Head of Unit - Food, Retail, Health
European Commission
Speakers
Falk Ehmann, MD, PhD
Head of Innovation and Development Accelerator
European Medicines Agency
Gerd A. Kullak-Ublick
Global Head, Mechanistic Safety and Safety Signal Management Patient Safety & Pharmacovigilance
Novartis
Carmen Laplaza-Santos, MA
Head of Unit Health Innovations and Ecosystems in Directorate General on Research and Innovation
European Commission
Kylie Sproston
Chief Executive Officer
Bellberry Limited

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS